• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增加体重负荷可通过减少肥胖参与者的脂肪量和腰围以及增加瘦体重来改善身体成分:一项单中心随机对照试验。

Increased weight-load improves body composition by reducing fat mass and waist circumference, and by increasing lean mass in participants with obesity: a single-centre randomised controlled trial.

作者信息

Bellman Jakob, Westerterp Klaas, Wouters Loek, Johannesson Marit, Lundqvist Niklas, Kullberg Joel, Larsson Christel, Gustafsson Mikael, Pettersson Stefan, Fridolfsson Jonatan, Arvidsson Daniel, Börjesson Mats, Curiac Dan, Jansson John-Olov, Jansson Per-Anders, Ohlsson Claes

机构信息

Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 11, SE-41390, Gothenburg, Sweden.

Department of Nutrition and Movement Sciences, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, NL-6200 MD, Maastricht, The Netherlands.

出版信息

BMC Med. 2025 May 30;23(1):317. doi: 10.1186/s12916-025-04143-6.

DOI:10.1186/s12916-025-04143-6
PMID:40442671
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC12123769/
Abstract

BACKGROUND

To investigate the effects of increased weight-loading on body weight, body composition, fat mass distribution, physical activity and energy balance in individuals with obesity.

METHODS

This single-centre non-blinded randomised controlled trial was conducted from August 1, 2021, through February 28, 2022. Adults with obesity class 1 (body mass index, BMI 30-35 kg/m) were assigned to wear either a heavy (high load; 11% of body weight, n = 28) or light (low load; 1% of body weight, n = 30) weight vest for 8 h per day over 5 weeks.

RESULTS

High-load treatment reduced fat mass (mean difference - 2.60%; 95% CI - 3.79, - 1.41) and increased lean mass (mean difference 1.40%; 95% CI 0.37, 2.42), with no significant effect on body weight. Fat mass reductions were primarily observed in weight-loaded regions but not in the non-weight-bearing regions such as the arms. Waist circumference decreased (mean difference - 2.26%; 95% CI - 3.81, - 0.71) in the high-load group compared to the low-load group. Despite these beneficial changes, sedentary time was higher in the high-load group (mean difference 4.69%; 95% CI 0.98, 8.39) compared to the low-load group, while energy expenditure and energy intake remained unchanged.

CONCLUSIONS

Increased weight-loading reduced fat mass and increased lean mass, resulting in a healthier body composition. These effects were achieved despite no increase in physical activity. The fat mass-reducing effect was primarily seen in weight-loaded regions, implying local adaptation to the increased loading.

TRIAL REGISTRATION

Registered at ClinicalTrials.gov (NCT04697238) in 2021.

摘要

背景

研究增加负重对肥胖个体的体重、身体成分、脂肪量分布、身体活动和能量平衡的影响。

方法

本单中心非盲随机对照试验于2021年8月1日至2022年2月28日进行。将1级肥胖成年人(体重指数,BMI 30 - 35kg/m)分为两组,一组每天佩戴重的(高负荷;体重的11%,n = 28),另一组佩戴轻的(低负荷;体重的1%,n = 30)负重背心,持续5周,每天佩戴8小时。

结果

高负荷治疗减少了脂肪量(平均差异 - 2.60%;95%置信区间 - 3.79, - 1.41),增加了瘦体重(平均差异1.40%;95%置信区间0.37,2.42),对体重无显著影响。脂肪量减少主要出现在负重区域,而非手臂等非负重区域。与低负荷组相比,高负荷组的腰围降低(平均差异 - 2.26%;95%置信区间 - 3.81, - 0.71)。尽管有这些有益变化,但与低负荷组相比,高负荷组的久坐时间更长(平均差异4.69%;95%置信区间0.98,8.39),而能量消耗和能量摄入保持不变。

结论

增加负重减少了脂肪量,增加了瘦体重,从而使身体成分更健康。尽管身体活动没有增加,但仍取得了这些效果。脂肪量减少的效果主要出现在负重区域,这意味着身体对增加的负荷产生了局部适应。

试验注册

2021年在ClinicalTrials.gov(NCT04697238)注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7eb/12123769/eebb94354e35/12916_2025_4143_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7eb/12123769/2fc95e17674b/12916_2025_4143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7eb/12123769/dae6669297da/12916_2025_4143_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7eb/12123769/3085e8846bef/12916_2025_4143_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7eb/12123769/eebb94354e35/12916_2025_4143_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7eb/12123769/2fc95e17674b/12916_2025_4143_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7eb/12123769/dae6669297da/12916_2025_4143_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7eb/12123769/3085e8846bef/12916_2025_4143_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7eb/12123769/eebb94354e35/12916_2025_4143_Fig4_HTML.jpg

相似文献

1
Increased weight-load improves body composition by reducing fat mass and waist circumference, and by increasing lean mass in participants with obesity: a single-centre randomised controlled trial.增加体重负荷可通过减少肥胖参与者的脂肪量和腰围以及增加瘦体重来改善身体成分:一项单中心随机对照试验。
BMC Med. 2025 May 30;23(1):317. doi: 10.1186/s12916-025-04143-6.
2
Effects of total fat intake on bodyweight in children.儿童总脂肪摄入量对体重的影响。
Cochrane Database Syst Rev. 2018 Feb 15;2(2):CD012960. doi: 10.1002/14651858.CD012960.
3
Effects of total fat intake on bodyweight in children.儿童总脂肪摄入量对体重的影响。
Cochrane Database Syst Rev. 2018 Jul 5;7(7):CD012960. doi: 10.1002/14651858.CD012960.pub2.
4
Low-carbohydrate versus balanced-carbohydrate diets for reducing weight and cardiovascular risk.低碳水化合物饮食与均衡碳水化合物饮食在减轻体重和降低心血管风险方面的比较。
Cochrane Database Syst Rev. 2022 Jan 28;1(1):CD013334. doi: 10.1002/14651858.CD013334.pub2.
5
Similar body composition outcomes following volumetric diet and time-restricted eating in middle-aged individuals: a 12-week randomized controlled trial.中年个体采用定量饮食和限时进食后的相似身体成分结果:一项为期12周的随机对照试验。
Nutr J. 2025 Jun 18;24(1):94. doi: 10.1186/s12937-025-01167-9.
6
The Impact of Digital Technology-Based Exercise Combined With Dietary Intervention on Body Composition in College Students With Obesity: Prospective Study.基于数字技术的运动联合饮食干预对肥胖大学生身体成分的影响:前瞻性研究
J Med Internet Res. 2025 Jun 2;27:e65868. doi: 10.2196/65868.
7
Randomised waitlist-controlled trial of a 10-week community programme using a plant-based diet in a predominantly Māori population in Tairāwhiti (Gisborne).在泰拉维提(吉斯伯恩)以毛利人为主的人群中,进行一项为期10周、采用植物性饮食的社区项目的随机等待名单对照试验。
BMJ Open. 2025 Jun 25;15(6):e080946. doi: 10.1136/bmjopen-2023-080946.
8
Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomised controlled trials and cohort studies.降低总脂肪摄入量对体重的影响:随机对照试验和队列研究的系统评价和荟萃分析。
BMJ. 2012 Dec 6;345:e7666. doi: 10.1136/bmj.e7666.
9
Nutritional supplementation for stable chronic obstructive pulmonary disease.稳定期慢性阻塞性肺疾病的营养补充
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD000998. doi: 10.1002/14651858.CD000998.pub3.
10
WITHDRAWN: Advice on low-fat diets for obesity.撤回:关于肥胖症低脂饮食的建议。
Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD003640. doi: 10.1002/14651858.CD003640.pub2.

引用本文的文献

1
Increased weight-bearing load reduces biological body weight while sodium and water balances are unaffected.增加负重负荷可降低生物体体重,而钠和水平衡不受影响。
Pflugers Arch. 2025 Sep 2. doi: 10.1007/s00424-025-03114-3.

本文引用的文献

1
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation.减肥对去脂体重、肌肉、骨骼和造血健康的影响:对旨在减少脂肪和保留瘦体重的新兴药物治疗的意义。
Metabolism. 2024 Dec;161:156057. doi: 10.1016/j.metabol.2024.156057. Epub 2024 Oct 30.
2
Improving the functional detection of sarcopenic obesity: prevalence and handgrip scoring in the OBESAR cohort.提高肌少症性肥胖的功能检测:OBESAR 队列中的患病率和握力评分。
Obesity (Silver Spring). 2024 Dec;32(12):2237-2245. doi: 10.1002/oby.24157. Epub 2024 Oct 28.
3
Skeletal muscle loss and sarcopenia in obesity pharmacotherapy.
肥胖症药物治疗中的骨骼肌丢失与肌肉减少症
Nat Rev Endocrinol. 2024 Dec;20(12):695-696. doi: 10.1038/s41574-024-01041-4.
4
Loading Enhances Glucose Uptake in Muscles, Bones, and Bone Marrow of Lower Extremities in Humans.负荷增加可增强人体下肢肌肉、骨骼和骨髓的葡萄糖摄取。
J Clin Endocrinol Metab. 2024 Nov 18;109(12):3126-3136. doi: 10.1210/clinem/dgae344.
5
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.SELECT 试验中的司美格鲁肽在非糖尿病肥胖患者中的长期减肥效果。
Nat Med. 2024 Jul;30(7):2049-2057. doi: 10.1038/s41591-024-02996-7. Epub 2024 May 13.
6
Effectiveness and safety of drugs for obesity.肥胖症药物的有效性和安全性。
BMJ. 2024 Mar 25;384:e072686. doi: 10.1136/bmj-2022-072686.
7
Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults.全球范围内 1990 年至 2022 年体重不足和肥胖趋势:对 3663 项具有 2.22 亿儿童、青少年和成年人代表性的人群研究进行的汇总分析。
Lancet. 2024 Mar 16;403(10431):1027-1050. doi: 10.1016/S0140-6736(23)02750-2. Epub 2024 Feb 29.
8
Fundament for a methodological standard to process hip accelerometer data to a measure of physical activity intensity in middle-aged individuals.用于处理中年个体髋部加速度计数据以衡量身体活动强度的方法学标准基础。
Scand J Med Sci Sports. 2024 Jan;34(1):e14541. doi: 10.1111/sms.14541. Epub 2023 Nov 20.
9
Do Sit-Stand Tables Affect Physical Behavior and Body Composition Similarly in Normal-Weight and Overweight Office Workers? A Pilot Study.坐站两用办公桌对正常体重和超重办公人员的身体活动行为和身体成分的影响是否相似?一项初步研究。
IISE Trans Occup Ergon Hum Factors. 2023 Jul-Oct;11(3-4):81-93. doi: 10.1080/24725838.2023.2281964. Epub 2023 Nov 20.
10
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.司美格鲁肽在肥胖但无糖尿病患者中的心血管结局。
N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11.